Literature DB >> 12746254

Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis.

Antoni Xaubet1, Alejandra Marin-Arguedas, Sergio Lario, Julio Ancochea, Ferran Morell, Juan Ruiz-Manzano, Eulogio Rodriguez-Becerra, Jose M Rodriguez-Arias, Pablo Inigo, Sergi Sanz, Josep M Campistol, Joaquim Mullol, Cesar Picado.   

Abstract

Transforming growth factor-beta1 (TGF-beta1) is a cytokine that plays a key role in the development of idiopathic pulmonary fibrosis. There have been reports on the presence of two genetic polymorphisms in the DNA sequence encoding the leader sequence of the TGF-beta1 protein, located in codons 10 and 25. The objective of this study was to investigate the association between TGF-beta1 gene polymorphisms in codons 10 and 25 and the susceptibility to idiopathic pulmonary fibrosis and the progression of the disease. Compared with healthy control subjects (n = 140), patients with idiopathic pulmonary fibrosis (n = 128) showed no significant deviations in genotype or allele frequencies. One hundred and ten patients with idiopathic pulmonary fibrosis were followed up for 30.3 +/- 25 months. The presence of a proline allele at codon 10 was independently associated with a significant increase in alveolar arterial oxygen tension difference during follow-up, after controlling for the effect of treatment (coefficient = 0.59; 95% confidence intervals, 0.23 to 0.96; p = 0.002). These findings suggest that (1) TGF-beta1 gene polymorphisms in codons 10 and 25 do not predispose to the development of idiopathic pulmonary fibrosis; and (2) TGF-beta1 gene polymorphisms may affect disease progression in patients with idiopathic pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746254     DOI: 10.1164/rccm.200210-1165OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  56 in total

Review 1.  Human Fibrosis: Is There Evidence for a Genetic Predisposition in Musculoskeletal Tissues?

Authors:  Louis Dagneaux; Aaron R Owen; Jacob W Bettencourt; Jonathan D Barlow; Peter C Amadio; Jean P Kocher; Mark E Morrey; Joaquin Sanchez-Sotelo; Daniel J Berry; Andre J van Wijnen; Matthew P Abdel
Journal:  J Arthroplasty       Date:  2020-06-04       Impact factor: 4.757

2.  The genetic basis of idiopathic pulmonary fibrosis.

Authors:  Jonathan A Kropski; Timothy S Blackwell; James E Loyd
Journal:  Eur Respir J       Date:  2015-04-02       Impact factor: 16.671

Review 3.  Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Treat Respir Med       Date:  2006

Review 4.  Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis? A perspective.

Authors:  Gary W Hunninghake; Marvin I Schwarz
Journal:  Proc Am Thorac Soc       Date:  2007-08-15

5.  Protein tyrosine phosphatase α mediates profibrotic signaling in lung fibroblasts through TGF-β responsiveness.

Authors:  Yael Aschner; Anthony P Khalifah; Natalie Briones; Cory Yamashita; Lior Dolgonos; Scott K Young; Megan N Campbell; David W H Riches; Elizabeth F Redente; William J Janssen; Peter M Henson; Jan Sap; Nathalie Vacaresse; Andras Kapus; Christopher A G McCulloch; Rachel L Zemans; Gregory P Downey
Journal:  Am J Pathol       Date:  2014-03-17       Impact factor: 4.307

6.  Allelic diversity in the TGFB1 regulatory region: characterization of novel functional single nucleotide polymorphisms.

Authors:  Riddhish Shah; Brad Rahaman; Carolyn Katovich Hurley; Phillip E Posch
Journal:  Hum Genet       Date:  2005-12-14       Impact factor: 4.132

7.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

Review 8.  Antioxidants as potential therapeutics for lung fibrosis.

Authors:  Brian J Day
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

Review 9.  Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis.

Authors:  Michael Zeisberg; Raghu Kalluri
Journal:  Am J Physiol Cell Physiol       Date:  2012-12-19       Impact factor: 4.249

Review 10.  Update on gene modifiers in cystic fibrosis.

Authors:  Joseph M Collaco; Garry R Cutting
Journal:  Curr Opin Pulm Med       Date:  2008-11       Impact factor: 3.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.